Affimed
AFMD
$5.03
Share price
3.07%
Change (1 day)
458.89%
Change (1 year)
Categories
P/S ratio for Affimed (AFMD)
P/S ratio as of April 2024 (TTM): 8.54
According to Affimed 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.54173. At the end of 2023 the company had a P/S ratio of 10.4.
P/S ratio history for Affimed from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 10.4 | 142.77% |
| 2022 | 4.29 | -69.51% |
| 2021 | 14.1 | -17.84% |
| 2020 | 17.1 | 96.78% |
| 2019 | 8.71 | 22% |
| 2018 | 7.14 | -71.46% |
| 2017 | 25.0 | 192.04% |
| 2016 | 8.56 | -69.84% |
| 2015 | 28.4 | -15.44% |
| 2014 | 33.6 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | 14.6 | 70.64% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | N/A | N/A | 🇺🇸 USA |
 Agenus
AGEN | 1.59 | -81.43% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 0.0070 | -99.92% | 🇺🇸 USA |